{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T07:56:22Z","timestamp":1722758182182},"reference-count":21,"publisher":"Wiley","issue":"16","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1002\/pros.23096","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T10:34:12Z","timestamp":1442572452000},"page":"1951-1957","source":"Crossref","is-referenced-by-count":15,"title":["PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy"],"prefix":"10.1002","volume":"75","author":[{"given":"Ahmed","family":"Elshafei","sequence":"first","affiliation":[{"name":"Glickman Urological & Kidney Institute Cleveland Clinic Foundation; Cleveland Ohio"},{"name":"Urology Department; Al Kasr Al Aini Hospital; Cairo University; Giza Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Kent","family":"Chevli","sequence":"additional","affiliation":[{"name":"NY Department of Urology; Western New York Urology Associates; University at Buffalo School of Medicine and Biomedical Sciences; Cheektowaga Buffalo New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman S.","family":"Moussa","sequence":"additional","affiliation":[{"name":"Urology Department; Beni Suef University; Beni Suef Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onder","family":"Kara","sequence":"additional","affiliation":[{"name":"Glickman Urological & Kidney Institute Cleveland Clinic Foundation; Cleveland Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Chueh","sequence":"additional","affiliation":[{"name":"Glickman Urological & Kidney Institute Cleveland Clinic Foundation; Cleveland Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Walter","sequence":"additional","affiliation":[{"name":"NY Department of Urology; Western New York Urology Associates; University at Buffalo School of Medicine and Biomedical Sciences; Cheektowaga Buffalo New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Hatem","sequence":"additional","affiliation":[{"name":"Glickman Urological & Kidney Institute Cleveland Clinic Foundation; Cleveland Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianming","family":"Gao","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences Department; Cleveland Clinic; Cleveland Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Stephen","family":"Jones","sequence":"additional","affiliation":[{"name":"Glickman Urological & Kidney Institute Cleveland Clinic Foundation; Cleveland Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Duff","sequence":"additional","affiliation":[{"name":"NY Department of Urology; Western New York Urology Associates; University at Buffalo School of Medicine and Biomedical Sciences; Cheektowaga Buffalo New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"10.1002\/pros.23096-BIB0001|pros23096-cit-0001","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23096-BIB0002|pros23096-cit-0002","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23096-BIB0003|pros23096-cit-0003","doi-asserted-by":"crossref","first-page":"f325","DOI":"10.1136\/bmj.f325","article-title":"Prostate cancer screening and the management of clinically localized disease","volume":"346","author":"Wilt","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/pros.23096-BIB0004|pros23096-cit-0004","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.3390\/ijms140917767","article-title":"PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy","volume":"14","author":"Ruffion","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1002\/pros.23096-BIB0005|pros23096-cit-0005","first-page":"5975","article-title":"DD3: A new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23096-BIB0006|pros23096-cit-0006","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: A molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0007|pros23096-cit-0007","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","article-title":"Contemporary role of prostate cancer antigen 3 in the management of prostate cancer","volume":"60","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1002\/pros.23096-BIB0008|pros23096-cit-0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer","volume":"70","author":"Hessels","year":"2010","journal-title":"Prostate"},{"key":"10.1002\/pros.23096-BIB0009|pros23096-cit-0009","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2011.01.075","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0010|pros23096-cit-0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2012.07.030","article-title":"Initial prostate biopsy: Development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay","volume":"63","author":"Hansen","year":"2013","journal-title":"Eur Urol"},{"key":"10.1002\/pros.23096-BIB0011|pros23096-cit-0011","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): Development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/pros.23096-BIB0012|pros23096-cit-0012","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2008.06.038","article-title":"Predicting prostate cancer risk through incorporation of prostate cancer gene 3","volume":"180","author":"Ankerst","year":"2008","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0013|pros23096-cit-0013","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.juro.2006.09.025","article-title":"Development and external validation of an extended repeat biopsy nomogram","volume":"177","author":"Chun","year":"2007","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0014|pros23096-cit-0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00345-011-0818-5","article-title":"Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy Collaborative Group","volume":"30","author":"Ankerst","year":"2012","journal-title":"World J Urol"},{"key":"10.1002\/pros.23096-BIB0015|pros23096-cit-0015","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.juro.2012.11.015","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"189","author":"Nam","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0016|pros23096-cit-0016","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.urology.2006.09.059","article-title":"Health perceptions in patients who undergo screening and workup for prostate cancer","volume":"69","author":"Katz","year":"2007","journal-title":"Urology"},{"key":"10.1002\/pros.23096-BIB0017|pros23096-cit-0017","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/pcan.2008.21","article-title":"The measurement of psychological distress in men being investigated for the presence of prostate cancer","volume":"11","author":"Awsare","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1002\/pros.23096-BIB0018|pros23096-cit-0018","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/01.ju.0000158039.94467.5d","article-title":"Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen","volume":"173","author":"Karakiewicz","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/pros.23096-BIB0019|pros23096-cit-0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.urology.2011.04.042","article-title":"Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information","volume":"78","author":"Zaytoun","year":"2011","journal-title":"Urology"},{"key":"10.1002\/pros.23096-BIB0020|pros23096-cit-0020","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1464-410X.2010.09286.x","article-title":"The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: Does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?","volume":"106","author":"Ploussard","year":"2010","journal-title":"BJU Int"},{"key":"10.1002\/pros.23096-BIB0021|pros23096-cit-0021","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23096","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pros.23096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T01:07:49Z","timestamp":1533517669000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pros.23096"}},"subtitle":["PCA3 Nomogram, Prostate Cancer"],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":21,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23096","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}